Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

SILDENAFIL 100 MG TABLET

sildenafil
$0.2546per EA

Strength

100 mg/1

Manufacturer

TruPharma LLC

NDC

52817034230

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

12/21/2022

Active Ingredients

SILDENAFIL CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA204882

On Market Since

7/1/2018

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

-22.2%

All

-63.9%

Generic Alternatives

Save up to 48%

1 alternative • Same active ingredient

SILDENAFIL 100 MG TABLET
Generic
72888001700•Advagen Pharma Ltd.
$0.1333
Save 48%

Related Drugs

Same classification

SILDENAFIL 20 MG TABLET
Generic
00904667104•Major Pharmaceuticals
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
00904667106•Major Pharmaceuticals
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
13668018590•Torrent Pharmaceuticals Limited
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
27241012403•Ajanta Pharma USA Inc.
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
27241012405•Ajanta Pharma USA Inc.
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
31722077605•Camber Pharmaceuticals Inc.
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
31722077690•Camber Pharmaceuticals Inc.
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
33342012110•Macleods Pharmaceuticals Limited
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
33342053610•Macleods Pharmaceuticals Limited
$0.0514
per EA
SILDENAFIL 20 MG TABLET
Generic
50268071715•AvPAK
$0.0514
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy